Allergy Diagnostics and Therapeutics Market Size Worth USD 78.51 Billion by 2034 | CAGR: 8.5%
The allergy diagnostics and therapeutics market size is expected to reach USD 78.51 billion by 2034, according to a new study by Polaris Market Research. The report “Allergy Diagnostics and Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Type (Diagnostics and Therapeutics), Allergen Type, Test Type, Product, Drug Class, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Allergy Diagnostics and Therapeutics refer to the methods and treatments used to identify and manage allergic reactions in individuals. Allergy diagnostics involve a variety of tests to determine specific allergens that trigger allergic responses, such as skin prick tests, blood tests, and molecular diagnostics. These tests help healthcare providers pinpoint the cause of allergies, whether it be environmental factors, food, or other substances.
The allergy diagnostics and therapeutics market is experiencing a significant growth, driven by the increasing prevalence of allergies worldwide, including conditions such as asthma, rhinitis, and food allergies.
Key drivers include rising environmental pollution, urbanization, and lifestyle changes, which are contributing to higher allergy rates. Technological advancements in diagnostic tools, such as multiplex testing and molecular diagnostics, are enhancing accuracy and speed in identifying allergens. Opportunities lie in the growing demand for personalized treatments, including allergy immunotherapy, and expanding access to allergy management solutions in emerging markets.
Allergy Diagnostics and Therapeutics Market Report Highlights
- The diagnostics segment dominates the market due to the increasing demand for accurate and efficient allergy testing methods, while the therapeutics segment is also registering the fastest growth, driven by the rising adoption of allergy immunotherapy treatments.
- The food segment holds the largest allergy diagnostics and therapeutics market share, with a growing number of food allergies globally, while the inhaled segment is experiencing the fastest growth due to rising respiratory allergies fueled by environmental pollution and urbanization.
- The in-vitro test segment leads the market due to the preference for non-invasive, highly accurate blood tests, while the in-vivo test segment is seeing the highest growth, particularly in clinical settings for faster, direct allergy diagnoses.
- North America dominates the market, driven by advanced healthcare infrastructure and high allergy prevalence, while Asia Pacific is the fastest growing region, fueled by increasing allergy awareness, urbanization, and improving healthcare systems.
Where is the Allergy Diagnostics and Therapeutics Market Headed?
Our research on the allergy diagnostics and therapeutics industry shows that technological advancements in diagnostic tools are expected to provide lucrative opportunities during the forecast period. The in-vivo test segment will register the highest growth during 2025–2034. The rising adoption of skin prick tests and patch tests, which offer fast, reliable results for diagnosing specific allergens, will boost the segment expansion.
Geographic analysis of the market, the Asia Pacific allergy diagnostics and therapeutics market is witnessing rapid growth. The rising incidence of allergic conditions, particularly in countries such as China, India, and Japan, will propel the regional market expansion in the coming years.
What Does the Allergy Diagnostics and Therapeutics Report Reveal?
- What is the global market size, emerging trends, and CAGR for the market through 2034?
- Which factors are fueling the industry growth?
- Who are the key industry players, and what is their relative position in terms of competitive positioning?
- How do different types, such as diagnostics and therapeutics, influence the market landscape?
- How does the market differ in terms of type, allergen type, test type, product, drug class, end user, and geography, and which are the leading target end users?
- What are the key trends in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa?
- Where do new opportunities arise in the market?
Request a free sample copy or read the full market insights: Allergy Diagnostics and Therapeutics Market
Polaris Market Research has segmented the allergy diagnostics and therapeutics market report based on type, allergen type, test type, product, drug class, end user, and region:
By Type Outlook (Revenue-USD Billion, 2020 – 2034)
- Diagnostics
- Therapeutics
By Allergen Type Outlook (Revenue-USD Billion, 2020 – 2034)
- Food
- Inhaled
- Drug
- Others
By Test Type Outlook (Revenue-USD Billion, 2020 – 2034)
- In-vivo Test
- In-vitro Test
By Product Outlook (Revenue-USD Billion, 2020 – 2034)
- Consumables
- Instruments
- Services
By Drug Class Outlook (Revenue-USD Billion, 2020 – 2034)
- Corticosteroids
- Antihistamines
- Leukotriene Inhibitors
- Decongestants
- Nasal Anticholinergics
- Others
By End User Outlook (Revenue-USD Billion, 2020 – 2034)
- Hospitals
- Diagnostics Labs
- Research & Development Centers
- Others
By Regional Outlook (Revenue-USD Billion, 2020 – 2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Allergy Diagnostics and Therapeutics Market Report Scope
| Report Attributes | Details |
| Market Size Value in 2024 | USD 34.64 billion |
| Market Size Value in 2025 | USD 37.52 billion |
| Revenue Forecast in 2034 | USD 78.51 billion |
| CAGR | 8.5% from 2025 to 2034 |
| Base Year | 2024 |
| Historical Data | 2020–2023 |
| Forecast Period | 2025–2034 |
| Quantitative Units | Revenue in USD billion and CAGR from 2025 to 2034 |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Industry Trends |
| Segments Covered | By Type Outlook By Allergen Type Outlook By Test Type Outlook By Product Outlook By Drug Class Outlook By End User Outlook |
| Regional Scope |
|
| Competitive Landscape |
|
| Report Format |
|
| Customization | Report customization as per your requirements with respect to countries, regions, and segmentation. |
| For Specific Research Requirements | Request Customization |
